FACTORS RELATED TO FEMALE COCAINE ABUSE

1988年家庭药物调查，由美国国家药物研究所委托进行 药物滥用的调查显示，尽管可卡因的年使用量在 在过去的三年里，频繁使用可卡因(每周)的情况有所增加。这 增加的主要原因是引入了一种强效可卡因--可卡因 衍生品，这是越来越多的妇女使用的。 研究的主要目的是描述和比较女性IV， 在六个概念领域内吸食和打击可卡因滥用：毒品-- 相关行为、社会支持、家庭功能、身体和精神 健康/疾病，以及感知的治疗需求。这是描述性的， 探索性研究采用相关设计，样本为雪球。 调查数据，使用两组可卡因的面对面访谈 虐待妇女：A组，已进入戒毒所的人 每周使用超过100.00美元的可卡因；B组，早期的朋友 受试者，虽然不一定在治疗中，但符合样本 标准和使用超过100.00美元/周。在两个小时的数据中 收集环节，每个受试者都将接受客户采访， 田纳西自我概念量表、贝克抑郁量表、个人资源 调查问卷和家庭基因图谱。目标样本量为200。数据 将允许描述性分析和数据完整性评估， 相关分析，并在需要时建立统计模型 数据。此外，还将使用以下方法进行分组分析 描述性测试和两个样本测试。

The 1988 Household Drug Survey, commissioned by the National Institute of Drug Abuse, revealed that although yearly cocaine use has decreased in the past three years, frequent cocaine use (weekly) has increased. This increase is primarily due to the introduction of crack, a potent cocaine derivative, which is being used by women with increasing frequency. The major aims of the research study are to describe and compare female iV, inhalation and crack cocaine abuse within six conceptual areas: drug- related behaviors, social support, family functioning, physical nad mental health/illness, and perceived treatment needs. This descriptive, exploratory study uses a correlational design with a snow-ball sample. Survey data, using face-to-face interviews from two groups of cocaine abusing women: Group A, those who have entered a drug treatment facility and use more than $100.00/week of cocaine; and Group B, friends of earlier subjects who, although not necessarily in treatment, meet the sample criteria and use greater than $100.00/week. During the two-hour data collection session, each subject will be administered the Client Interview, Tennessee Self-Concept Scale, Beck Depression Inventory, Personal Resource Questionnaire and a Family Genogram. Target sample size is 200. The data will allow for descriptive analyses and assessment of data integrity, correlational analyses, and when required, statistical modeling of the data. Additionally, subgroup analyses will be carried out using descriptive as well as two sample tests.